AIDS and Tuberculosis Co-infection Treatment Strategies Study of China.[ Eleven Fifth Key Research Grant From the Ministry of Science and Technology, the People's Republic of China]

NCT01344148 NA UNKNOWN

To determine the best time to begin anti-HIV(Acquired Immunodeficiency Syndrome) treatment in individuals who co-infected with HIV and tuberculosis (Tb). This prospective, randomized study is being conducted on HIV/Tb co-infected patients in China to evaluate and compare the efficacy of antiretroviral therapy after 2 weeks TB treatment versus deferred ART initiated 8 weeks after initiation of TB treatment.

Details

Lead sponsor	Shanghai Public Health Clinical Center
Phase	NA
Status	UNKNOWN
Enrolment	400
Start date	2009-02
Completion	2013-06

Conditions

• AIDS

Interventions

• INH RIF Rifb PZA EMB AZT 3TC D4T EFV

Primary outcomes

• Number of Participants with Adverse Events as a Measure of Safety and Tolerability — 3 years
  In China TB is the main co-infected disease of AIDS patients. This study will give the evidence for make the HIV and TB Co-infected Patients therapy tactics of China. At first, the study will prove what is the best time for begin HAART after anti-TB therapy 2 weeks or 8 weeks. And anti-TB and HAART program will also be confirmed in this study. Overall this research will measure the HIV and TB co-infected patients clinical treatment safety and tolerability of China.

Countries

China